Abstract
Real strides have been made in the last decade in the treatment of sudden cardiac death. Survival rates from out-of-hospital cardiac arrest (CA) have been reported as low as 1 and 2% in large cities (1,2). Communities with rapid emergency response teams have reported better results with survival rates from 15 to 30% (3). Within the last few years providing early defibrillation by equipping nonmedical first responders with automated external defibrillators (AEDs) has been a crucial step in improving survival from out-of-hospital CA. Recent reports from Rochester, Minnesota, where police are now providing early defibrillation, have shown a community-wide survival rate of 40% for patients whose initial rhythm is ventricular fibrillation (VF [4]). Casinos in which security personnel were trained to use AEDs have reported overall survival rates from VF of 59% for victims of sudden CA on property (5). Similarly, the Chicago Airport Authority experience has been impressive (6,7). After placing AEDs in the terminals of both O’Hare and Midway airports, they found a 56% neurologically normal survival rate for VF CA within the first 24 months of starting this public access defibrillation program.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Lombardi G, Gallagher J, P. G. Outcome of out-of-hospital cardiac arrest in New York City: the Pre-Hospital Arrest Survival Evaluation (PHASE) study. JAMA 1994; 271:678–683.
Becker L, Ostrander M, Barrett J, Kondos G. CPR Chicago: outcome of cardiopulmonary resuscitation in a large metropolitan area-where are the survivors? Ann Emerg Med 1991; 20:355–361.
Cummins R, Ornato J, Theis W, Pepe P. Improving Survival From Sudden Cardiac Arrest: The “Chain of Survival” Concept. Circulation 1991; 83:1832–1847.
White R, Hankins D, Bugliosi T. Seven years’ experience with early defibrillation by police and paramedics in an emergency medical services system. Resuscitation 1998; 39:145–151.
Valenzuela TD, Roe DJ, Nichol G, Clark LL, Spaite DW, Hardman RG. Outcomes of rapid defibrillation by security officers after cardiac arrest in casinos. [see comments.]. N Engl J Med 2000; 343: 1206–1209.
Willoughby P, Caffrey S. Improved survival with an airport-based PAD program. Circulation 2000; 102:II-828.
Caffrey S, Willoughby P, Pepe P, Becker L. Public use of automated external defibrillators. N Engl J Med 2002; 347:1242–1247.
Kudenchuk PJ, Cobb LA, Copass MK, et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. [see comments.]. N Engl J Med 1999; 341:871–878.
Dorian P, Cass D, Schwartz B, Cooper R, Gelaznikas R, Barr A. Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation. N Engl J Med 2002; 346:884–890.
Centers for Disease Control and Prevention (CDC). State-Specific Mortality From Sudden Cardiac Death—United States, 1999. MMWR 2002; 51; 123–126.
Group BRCTIS. Brain Resuscitation Clinical Trial I Study Group: A randomized clinical study of thiopental loading in comatose survivors of cardiac arrest. N Engl J Med 1986; 314:397–403.
Group BRCTIS. Brain Resuscitation Clinical Trial II Study Group: A randomized clinical study of a calcium-entry blocker (lidoflazine) in the treatment of comatose survivors of cardiac arrest. N Engl J Med 1991; 324:1125–1131.
Schoenenberger RA, von Planta M, von Planta I. Survival after failed out-of-hospital resuscitation. Are further therapeutic efforts in the emergency department futile? Arch Int Med 1994; 154:2433–2437.
Ewy GA, Ornato JP. 31st Bethesda Conference: Emergency Cardiac Care (1999), Bethesda Conference Report, Bethesda, Maryland. 1999; Vol. 35. J Am Coll Cardiol.
Becker LB, Weisfeldt ML, Weil MH, et al. The PULSE initiative: scientific priorities and strategic planning for resuscitation research and life saving therapies. Circulation 2002; 105:2562–2570.
Cerchiari EL, Safar P, Klein E, Cantadore R, Pinsky M. Cardiovascular function and neurologic outcome after cardiac arrest in dogs. The cardiovascular post-resuscitation syndrome. Resuscitation 1993; 25:9–33.
Tang W, Weil MH, Sun S, Gazmuri RJ, Bisera J. Progressive myocardial dysfunction after cardiac resuscitation. Crit Care Med 1993; 21:1046–1050.
Gazmuri RJ, Weil MH, Bisera J, Tang W, Fukui M, McKee D. Myocardial dysfunction after successful resuscitation from cardiac arrest. Crit Care Med 1996; 24:992–1000.
Kern KB, Hilwig RW, Rhee KH, Berg RA. Myocardial dysfunction after resuscitation from cardiac arrest: an example of global myocardial stunning. J Am Coll Cardiol 1996; 28:232–240.
Patel B, Kloner RA, Przyklenk K, Braunwald E. Postischemic myocardial “stunning”: A clinically relevant phenomenon. Ann Intern Med 1988; 108:626–628.
Wijns W, Serruys P, Slager C, et al. Effect of coronary occlusion during percutaneous transluminal angioplasty in humans on left ventricular chamber stiffness and regional diastolic pressure-radius relations. J Am Coll Cardiol 1986; 7:455–463.
Meyer RJ, Kern KB, Berg RA, Hilwig RTW, Ewy GA. Post-resuscitation right ventricular dysfunction: delineation and treatment with dobutamine. Resuscitation. 2002; 55:187–191.
Bowers TR, O’Neill WW, Grines C, Pica MC, Safian RD, Goldstein JA. Effect of Reperfusion on Biventricular Function and Survival after Right Ventricular Infarction. N Engl J Med 1998; 338:933–940.
Kern KB, Garewal HS, Sanders AB, et al. Depletion of myocardial adenosine triphosphate during prolonged untreated ventricular fibrillation: effect on defibrillation success. Resuscitation 1990; 20:221–229.
Kamohara T, Weil MH, Tang W, et al. A comparison of myocardial function after primary cardiac and primary asphyxial cardiac arrest. Am J Respir Crit Care Med 2001; 164:1221–1224.
Deantonio HJ, Kaul S, Lerman BB. Reversible myocardial depression in survivors of cardiac arrest. Pacing Clin Electrophysiol 1990; 13:982–985.
Bashir R, Padder FA, Khan FA. Myocardial stunning following respiratory arrest. Chest 1995; 108: 1459–1460.
Kern KB. Post resuscitation left ventricular dysfunction: acute reversible heart failure. Cardinale (French) 1998; 10:16–18.
Laurent I, Spaulding C, Monchi M, et al. Transient shock after successful resuscitation: clinical evidence for post-cardiac arrest myocardial stunning. J Am Coll Cardiol 2000; 35:399A.
Mullner M, Domanovits H, Sterz F, et al. Measurement of myocardial contractility following successful resuscitation: quantitated left ventricular systolic function utilizing non-invasive wall stress analysis. Resuscitation 1998; 39:51–59.
Tang W, Weil MH, Sun S. Low-energy biphasic waveform defibrillation reduces the severity of postresuscitation myocardial dysfunction. Crit Care Med 2000; 28:N222–N224.
Tang W, Weil MH, Sun S, Noc M, Yang L, Gazmuri RJ. Epinephrine increases the severity of postresuscitation myocardial dysfunction. Circulation 1995; 92:3089–3093.
Sun S, Weil MH, Tang W, Kamohara T, Klouche K. Alpha-Methylnorepinephrine, a selective alpha2-adrenergic agonist for cardiac resuscitation. J Am Coll Cardiol 2001; 37:951–956.
Klouche K, Weil MH, Tang W, Povoas H, Kamohara T, Bisera J. A selective alpha(2)-adrenergic agonist for cardiac resuscitation. J Lab Clin Med 2002; 140:27–34.
Hilwig RW, Berg RA, Kern KB, Ewy GA. Endothelin-1 vasoconstriction during swine cardiopulmonary resuscitation improves coronary perfusion pressures but worsens postresuscitation outcome. Circulation 2000; 101:2097–2102.
Kette F, Weil MH, von Planta M, Gazmuri RJ, Rackow EC. Buffer agents do not reverse intramyocardial acidosis during cardiac resuscitation. Circulation 1990; 81:1660–1666.
Kette F, Weil MH, Gazmuri RJ. Buffer solutions may compromise cardiac resuscitation by reducing coronary perfusion pressure. [see comments.] [erratum appears in JAMA 1991 Dec 18; 266(23):3286.]. JAMA 1991; 266:2121–2126.
Sun S, Weil MH, Tang W, Fukui M. Effects of buffer agents on postresuscitation myocardial dysfunction. Crit Care Med 1996; 24:2035–2041.
Sun S, Weil MH, Tang W, Povoas HP, Mason E. Combined effects of buffer and adrenergic agents on postresuscitation myocardial function. J Pharm Exp Ther 1999; 291:773–777.
Xie J, Weil MH, Sun S, et al. High-energy defibrillation increases the severity of postresuscitation myocardial dysfunction. Circulation 1997; 96:683–688.
Caterine MR, Spencer KT, Pagan-Carlo LA, Smith RS, Buettner GR, Kerber RE. Direct current shocks to the heart generate free radicals: an electron paramagnetic resonance study. J Am Coll Cardiol 1996; 28:1598–1609.
Tang W, Weil MH, Sun S, et al. The effects of biphasic and conventional monophasic defibrillation on postresuscitation myocardial function. [see comments.]. J Am Coll Cardiol 1999; 34:815–822.
Niemann JT, Burian D, Garner D, Lewis RJ. Monophasic versus biphasic transthoracic countershock after prolonged ventricular fibrillation in a swine model. [see comments.]. J Am Coll Cardiol 2000; 36:932–938.
Sun S, Klouche K, Tang W, Weil MH. The effects of biphasic and conventional monophasic defibrillation on postresuscitation myocardial function. [letter; comment.]. J Am Coll Cardiol 2001; 37:1753,1754.
Cohn LH. Dobutamine in the postcardiac surgery patient. In: Chatterjee K, ed. Dobutamine: A Ten-Year Review. Indianapolis, IN: Eli Lilly, 1989, pp. 123–128.
Berrizbeitia LD, Piccione W, Austin JC, et al. Inotropic response of the salvaged myocardium after acute coronary occlusion. Ann Thorac Surg 1986; 41:58–64.
Kern KB, Hilwig RW, Berg RA, et al. Postresuscitation left ventricular systolic and diastolic dysfunction. Treatment with dobutamine. Circulation 1997; 95:2610–2613.
Tennyson H, Kern KB, Hilwig RW, Berg RA, Ewy GA. Treatment of post resuscitation myocardial dysfunction: aortic counterpulsation versus dobutamine. Resuscitation 2002; 54:69–75.
Vasquez A, Kern K, Hilwig R, Heidenreich JW, Berg RA, Ewy GA. Dobutamine for post-resuscitation left ventricular dysfunction: an assessment of optimal dosing. Resuscitation 2004; 61:199–207.
Tang W, Weil MH, Sun S, Pernat A, Mason E. K(ATP) channel activation reduces the severity of postresuscitation myocardial dysfunction. Am J Physiol Heart Circ Physiol 2000; 279:H1609–H1615.
Kamohara T, Weil MH, Tang W, Sun S, Klouche K, Zhao D. Improved function and survival after administration of 21-aminosteriods during CPR. Circulation 2000; 102:II-571.
The Hypothermia after Cardiac Arrest Study G. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. [see comments.] [erratum appears in N Engl J Med 2002 May 30; 346(22):1756.]. N Engl J Med 2002; 346:549–556.
Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. [see comments.]. N Engl J Med 2002; 346:557–563.
Leonov Y, Sterz F, Safar P, Radovsky A. Moderate hypothermia after cardiac arrest of 17 minutes in dogs. Effect on cerebral and cardiac outcome. Stroke 1990; 21:1600–1606.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Vasquez, A., Kern, K.B. (2005). Myocardial Dysfunction Postresuscitation. In: Ornato, J.P., Peberdy, M.A. (eds) Cardiopulmonary Resuscitation. Contemporary Cardiology. Humana Press. https://doi.org/10.1385/1-59259-814-5:503
Download citation
DOI: https://doi.org/10.1385/1-59259-814-5:503
Publisher Name: Humana Press
Print ISBN: 978-1-58829-283-4
Online ISBN: 978-1-59259-814-4
eBook Packages: MedicineMedicine (R0)